Clinical Trials Browser

Has results × Urinary Bladder Neoplasms × Bevacizumab × Clear all

NCT00268450 2018-07-12

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Phase 2 Terminated

21 enrolled 4 charts

Urinary Bladder Neoplasms

NCT00506155 2016-03-31

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer

Phase 2 Completed

60 enrolled 10 charts

Urinary Bladder Neoplasms

NCT00234494 2016-03-14

Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer

Phase 2 Completed

45 enrolled 11 charts

Urinary Bladder Neoplasms